News

A study commissioned by three of the UK’s leading scientific institutions has demonstrated substantial financial and social benefits from investment in medical research.

Cancer Research UK (CRUK) launched a five-year plan which will see the charity spend around GBP 300 million a year on core areas of science in a bid to reduce cancer deaths, including greater investment in cancers where survival rates are poor.

In a time of uncertainty, venture capitalists are shifting from biotech to the lower-risk, lower-reward field of MedTech.

Academic entrepreneurs from across Europe were named last night as the winners of the inaugural Academic Enterprise Awards 2008, at a ceremony in Stockholm, Sweden.

US genomics firm Myriad Genetics regains limited rights to BRCA1 breast cancer gene on final appeal.

Select companies can still find funding from venture capitalists and the public market; others are using the depressed economy to cut costs.

Bosnia and Herzegovina have signed a memorandum of understanding with the European Commission, allowing full access to the 7th Research Framework Programme.

Governments need to increase international cooperation and strengthen links between public research bodies and industry, says a new OECD report.